Process and intermediates for the preparation of perampanel
AssigneeMapi Pharma Ltd.
InventorsEhud MAROM, Shai RUBNOV
Life of this patent
Estimating the term…
Abstract
The present invention describes a process for the synthesis of 3-(2-cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-di-hydro-pyridin-2-one (Perampanel) represented by the structure of formula (1), and salts thereof, especially salts with pharmaceutically acceptable acids. The present invention further relates to certain intermediates formed and/or used in such process.
Claims22
1-27. (canceled)
A process for the preparation of 3-(2-cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2 dihydro-pyridin-2-one (Perampanel) represented by the structure of formula (1), and salts thereof,
- comprising the following steps:
- a). reacting a compound of formula (2) with a formylating agent to form a compound of formula (3)
- wherein
- Y is OR2 or NR3R4;
- R1, R2, R3 and R4 are each independently a (C1-C4)-alkyl or an aryl;
- and
- X is a group that can be converted to a CN group;
- b). reacting compound (3) with aniline to form a compound of formula (4):
- c). cyclizing the compound of formula (4) to form a compound of formula (5):
- and
- d). converting compound (5) to 3-(2-cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-one (1) (Perampanel). 29 (New):
- The process according to claim 28, wherein X is selected from the group consisting of halogen, acetal, —C(═O)H, —C(═N)—OH, —C(═O)NH2, sulfonyloxy, NHZ1 wherein Z is H or a nitrogen protecting group, and OZ2 wherein Z2 is a H or a hydroxy protecting group.
The process according to claim 29, wherein X is a sulfonyloxy selected from the group consisting of mesylate (Ms), tosylate (Ts) and triflate (Tf);
- or wherein X is an acetal represented by the structure CH(OR5)2 wherein each R5 is independently a C1-C4 alkyl, or wherein CH(OR5)2 represents cyclic acetal, preferably 1,3-dioxane or 1,3-dioxolane.
The process according to claim 28, wherein Y is OR2 and the process comprises the steps of:
- a). reacting a compound of formula (2) with a formylating agent selected from the group consisting of an alkyl formate and a trialkyl orthoformate to form a compound of formula (6):
- b). reacting compound (6) with aniline to form a compound of formula (7):
- c). cyclizing the compound of formula (7) to a compound of formula (5)
- and
- d). converting of compound (5) to Perampanel (1). 34 (New):
- The process according to claim 33, wherein the formylating agent in step (a) is a trialkyl orthoformate, and compound (2) is converted directly to compound (6).
A compound represented by the structure of formula (5);
- wherein X is selected from the group consisting of halogen, acetal, —C(═O)H, —C(═N)—OH, C(═O)NH2, sulfonyloxy, NHZ1 wherein Z is H or a nitrogen protecting group, and OZ2 wherein Z2 is a H or hydroxy protecting group.
Dependencies are inferred from the claim text.